Douglas Fink

860 total citations
31 papers, 331 citations indexed

About

Douglas Fink is a scholar working on Infectious Diseases, Epidemiology and General Health Professions. According to data from OpenAlex, Douglas Fink has authored 31 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 7 papers in Epidemiology and 5 papers in General Health Professions. Recurrent topics in Douglas Fink's work include HIV Research and Treatment (4 papers), interferon and immune responses (3 papers) and COVID-19 Clinical Research Studies (2 papers). Douglas Fink is often cited by papers focused on HIV Research and Treatment (4 papers), interferon and immune responses (3 papers) and COVID-19 Clinical Research Studies (2 papers). Douglas Fink collaborates with scholars based in United Kingdom, United States and Switzerland. Douglas Fink's co-authors include Nina Goldman, Zoe Davies, Greg J. Towers, Michael J. Malloy, Rebecca P. Sumner, F Martín, B D Weintraub, Neil Gesundheit, Robert F. Miller and Lucy Thorne and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and PEDIATRICS.

In The Last Decade

Douglas Fink

29 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Douglas Fink United Kingdom 10 102 63 61 58 48 31 331
Zhengwei Wan China 12 80 0.8× 123 2.0× 31 0.5× 58 1.0× 26 0.5× 38 528
Aristotelis Tsiakalos Greece 9 70 0.7× 72 1.1× 27 0.4× 17 0.3× 23 0.5× 21 289
Paddy McMaster United Kingdom 11 140 1.4× 139 2.2× 38 0.6× 27 0.5× 15 0.3× 28 436
Triin Umbleja United States 13 104 1.0× 245 3.9× 31 0.5× 54 0.9× 20 0.4× 28 493
Regina Kuhmmer Brazil 13 96 0.9× 57 0.9× 74 1.2× 92 1.6× 18 0.4× 17 303
Nátalli Zanete Pereira Brazil 13 170 1.7× 91 1.4× 158 2.6× 38 0.7× 13 0.3× 29 525
Kara W Chew United States 15 193 1.9× 283 4.5× 43 0.7× 78 1.3× 9 0.2× 49 577
Fernando Mejía Peru 10 197 1.9× 109 1.7× 20 0.3× 42 0.7× 9 0.2× 37 346
Marc J. T. Blaauw Netherlands 9 149 1.5× 90 1.4× 69 1.1× 15 0.3× 28 0.6× 23 370
Margarida Tavares Portugal 10 79 0.8× 112 1.8× 11 0.2× 22 0.4× 19 0.4× 47 462

Countries citing papers authored by Douglas Fink

Since Specialization
Citations

This map shows the geographic impact of Douglas Fink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Fink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Fink more than expected).

Fields of papers citing papers by Douglas Fink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas Fink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Fink. The network helps show where Douglas Fink may publish in the future.

Co-authorship network of co-authors of Douglas Fink

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas Fink. A scholar is included among the top collaborators of Douglas Fink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas Fink. Douglas Fink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fink, Douglas, David Etoori, Robert Hill, et al.. (2025). Auto-antibodies against interferons are common in people living with chronic hepatitis B virus infection and associate with PegIFNα non-response. JHEP Reports. 7(5). 101382–101382.
2.
Fink, Douglas, Matthew V. X. Whelan, Christopher Monit, et al.. (2022). HIV-2/SIV Vpx antagonises NF-κB activation by targeting p65. Retrovirology. 19(1). 2–2. 11 indexed citations
3.
Fink, Douglas, David Oladele, Shumonta Quaderi, et al.. (2022). A multi-centre observational study of HIV, tuberculosis and risk of chronic lung disease in urban West Africa. AIDS. 36(14). 1987–1995. 9 indexed citations
4.
Fink, Douglas, et al.. (2021). ROX Index to Guide Management of COVID-19 Pneumonia. UCL Discovery (University College London). 1 indexed citations
5.
Goldman, Nina, et al.. (2020). High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care. Diabetes Research and Clinical Practice. 166. 108291–108291. 57 indexed citations
6.
Khan, Hataf, Rebecca P. Sumner, Jane Rasaiyaah, et al.. (2020). HIV-1 Vpr antagonizes innate immune activation by targeting karyopherin-mediated NF-κB/IRF3 nuclear transport. eLife. 9. 39 indexed citations
7.
Fink, Douglas, Palwasha Khan, Nina Goldman, et al.. (2020). Development and internal validation of a diagnostic prediction model for COVID-19 at time of admission to hospital. QJM. 114(10). 699–705. 10 indexed citations
8.
9.
Fink, Douglas, et al.. (2018). Assessing antibiotic stewardship using the surgical site infection prevention bundle. British Journal of Hospital Medicine. 79(11). 643–647. 5 indexed citations
10.
Fink, Douglas, et al.. (2018). Fever in the returning traveller. BMJ. 360. j5773–j5773. 11 indexed citations
11.
Fink, Douglas, et al.. (2018). Musculoskeletal symptoms and non-prescribed treatments are common in an urban African population of people living with HIV. Rheumatology International. 39(2). 285–291. 8 indexed citations
12.
Sumner, Rebecca P., Lucy Thorne, Douglas Fink, et al.. (2017). Are Evolution and the Intracellular Innate Immune System Key Determinants in HIV Transmission?. Frontiers in Immunology. 8. 1246–1246. 20 indexed citations
13.
Fink, Douglas, et al.. (2016). African sleeping sickness. British Journal of Hospital Medicine. 77(Sup10). C157–C160. 6 indexed citations
14.
Wilson, James P., Kalman Kafetz, & Douglas Fink. (2016). Lick of death:Capnocytophaga canimorsusis an important cause of sepsis in the elderly. BMJ Case Reports. 2016. bcr2016215450–bcr2016215450. 13 indexed citations
15.
Fink, Douglas, et al.. (2015). Blood culture fluorescence rates predict severity and mortality of invasive pneumococcal pneumonia. European Journal of Clinical Microbiology & Infectious Diseases. 34(8). 1559–1566. 1 indexed citations
16.
Aziz, Omer, et al.. (2011). Hospital mortality under surgical care. Annals of The Royal College of Surgeons of England. 93(3). 193–200. 7 indexed citations
17.
18.
Matter‐Walstra, Klazien, et al.. (2009). Bevacizumab in combination with paclitaxel for HER-2 negative metastatic breast cancer: an economic evaluation.. Cancer Research. 69(2_Supplement). 6104–6104. 1 indexed citations
19.
Haller, U., et al.. (2005). Von der Schuldfrage zur Fehlerkultur in der Medizin. Risiken, Fehler und Patientensicherheit. Schweizerische Ärztezeitung. 86(27). 1665–1679. 1 indexed citations
20.
Fink, Douglas, et al.. (1969). The management specialist in effective pediatric ambulatory care.. American Journal of Public Health and the Nations Health. 59(3). 527–533. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhengwei Wan Breakdown of academic impact, for papers by Aristotelis Tsiakalos Breakdown of academic impact, for papers by Paddy McMaster Breakdown of academic impact, for papers by Triin Umbleja Breakdown of academic impact, for papers by Regina Kuhmmer Breakdown of academic impact, for papers by Nátalli Zanete Pereira Breakdown of academic impact, for papers by Kara W Chew Breakdown of academic impact, for papers by Fernando Mejía Breakdown of academic impact, for papers by Marc J. T. Blaauw Breakdown of academic impact, for papers by Margarida Tavares
Rankless by CCL
2026